IRIS
TRIESTE, LEOPOLDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.276
EU - Europa 4.662
AS - Asia 3.244
SA - Sud America 757
AF - Africa 75
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 20
Totale 15.063
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.018
IT - Italia 1.390
SG - Singapore 1.342
RU - Federazione Russa 1.073
CN - Cina 782
GB - Regno Unito 664
BR - Brasile 610
DE - Germania 415
VN - Vietnam 395
UA - Ucraina 282
CA - Canada 197
KR - Corea 161
HK - Hong Kong 157
DK - Danimarca 147
SE - Svezia 98
FR - Francia 90
IN - India 87
FI - Finlandia 83
NL - Olanda 80
IE - Irlanda 67
PL - Polonia 61
AR - Argentina 59
TR - Turchia 50
ES - Italia 49
MX - Messico 42
JP - Giappone 39
ZA - Sudafrica 35
BE - Belgio 34
EC - Ecuador 34
BD - Bangladesh 33
AT - Austria 28
AU - Australia 27
ID - Indonesia 27
PH - Filippine 23
EU - Europa 20
IQ - Iraq 20
IL - Israele 19
PT - Portogallo 18
TW - Taiwan 18
PK - Pakistan 17
CO - Colombia 15
MY - Malesia 15
RO - Romania 14
CH - Svizzera 13
LT - Lituania 13
PY - Paraguay 11
PE - Perù 10
MA - Marocco 9
JO - Giordania 8
SA - Arabia Saudita 8
CL - Cile 7
KE - Kenya 6
VE - Venezuela 6
AZ - Azerbaigian 5
CY - Cipro 5
IR - Iran 5
LU - Lussemburgo 5
SN - Senegal 5
TN - Tunisia 5
UZ - Uzbekistan 5
AL - Albania 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
GR - Grecia 4
JM - Giamaica 4
KZ - Kazakistan 4
SI - Slovenia 4
TH - Thailandia 4
BY - Bielorussia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HN - Honduras 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
DM - Dominica 2
DZ - Algeria 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
UG - Uganda 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
Totale 15.052
Salva come PNG Salva come JPEG
Città #
Dallas 1.846
Singapore 779
Beijing 385
Chandler 375
Ashburn 366
Woodbridge 342
Southend 341
Houston 267
Pisa 214
San Mateo 175
Ann Arbor 170
Hong Kong 148
Jacksonville 142
Moscow 136
Fairfield 123
Los Angeles 118
Dearborn 105
Ho Chi Minh City 103
Daejeon 97
Seattle 97
Cambridge 90
Wilmington 89
Rome 88
Boardman 87
Falls Church 87
New York 85
Milan 79
Hefei 77
The Dalles 71
Beauharnois 70
São Paulo 69
Dong Ket 65
Seoul 62
Stevenage 61
Dublin 60
Portsmouth 59
Hanoi 55
Lawrence 55
Warsaw 54
Fremont 49
Brooklyn 47
Santa Clara 45
Florence 41
Munich 41
Buffalo 39
Denver 39
London 37
Salerno 37
Stockholm 36
Montreal 33
Serra 31
Bologna 30
Atlanta 28
Poplar 28
Johannesburg 27
Tokyo 26
Buti 25
Montréal 25
Helsinki 23
Redwood City 23
Chennai 22
Ankara 21
Old Bridge 21
Paris 21
Chicago 20
Phoenix 20
Ottawa 19
Boston 18
Lucca 18
Nuremberg 18
Orem 17
Rio de Janeiro 16
Genoa 15
Livorno 15
Mumbai 15
Toronto 15
Trento 15
Frankfurt am Main 14
Haiphong 14
Hamburg 14
Istanbul 14
Mexico City 14
Tel Aviv 14
Querétaro 13
San Francisco 13
Quito 12
Taipei 12
Turku 12
Vienna 12
Xi'an 12
Brussels 11
Da Nang 11
Guayaquil 11
Charlotte 10
Isleworth 10
Melbourne 10
Philadelphia 10
Porto Alegre 10
Torino 10
Dhaka 9
Totale 8.980
Salva come PNG Salva come JPEG
Nome #
Nutri-Score and Food Perception: Insights from an Italian Study 702
On Robots and Insurance 530
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 421
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 353
The Effect of using Serifs in Brand Names on Luxury Perception 325
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 316
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 296
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 278
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 273
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 263
A systematic literature review of the economic impact of ankylosing spondylitis 261
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 248
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 245
Is EEG Suitable for Marketing Research? A Systematic Review 245
Natural and man-made disasters: challenges and international perspectives for insurance 241
How colour saturation accelerates purchase behaviour, and influences food choice: 232
Assessing the value of the use of diagnostic technology: trade offs for GPs 232
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 232
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 232
Which indicators for measuring the daily physical activity? An overview on the challenges and technology limits for Telehealth applications 231
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 229
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 228
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 220
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 219
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 218
Are drug procurement procedure and award criteria in EU hospital setting standardized and do they take into account effective supply quality? 212
WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS 212
The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS) 209
Health information technologies in systemic lupus erythematosus: focus on patient assessment 208
Raiders of Lost Value 203
Columbus' egg and the engineer's effect in forecasting solutions adoption 201
Management and Treatment of Type 1 And 2 Diabetes: State of Art 201
Asessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo: Preliminary Data 201
Systemic vasculitis: how little we know about their societal and economic burden 200
KNOWLEDGE, USE AND DESIDERATA ABOUT INFORMATION AND COMMUNICATION TECHNOLOGIES SYSTEMS FOR SYSTEMIC LUPUS ERYTHEMATOSUS. PRELIMINARY RESULTS FROM THE INTEGRATE PILOT PROJECT 196
Conseguenze cliniche ed economiche dello switch ai biosimilari dell’Infliximab nei pazienti reumatologici in Toscana 194
The influence of parental Dietary Behaviors, food literacy and chronotype on Children’s eating habits and psychometric factors 193
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 193
Consideration on the Accuracy of Watch for Physical Activity Tracker 189
The definition of a new organizational, technology-based, integrated home care model 186
P56 Early Health Technology Assessment to Guide Introduction of Novel Technology into the Market: The Vostars System Case Study 184
The economic impact of gout: a systematic literature review 182
Food literacy and food purchase behaviour 181
Taste Your Consumer Audience. How Sensory Expertise Influences Food Choice 180
The cost of illness of ultra-rare Cryopyrin Associated Periodic Syndromes (CAPS) in Italy: Preliminary results from the Radicea project 180
Razionale e strumenti della valutazione economica in sanità 176
Being a caregiver of a Behçet’s syndrome patient: challenges and perspectives during a complex journey 175
TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol 165
Switching from infliximab‐originator to infliximab‐biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 165
Natura e ruolo degli indicatori nella logistica farmaceutica 159
Telemonitoring in Cystic Fibrosis: A 4-year Assessment and Simulation for the Next 6 Years 155
Innovazione tecnologica, dinamica del contesto economico e logistica in sanità 154
Farmaci per le patologie autoimmuni. Traiettorie di trattamento nell’artrite reumatoide 153
Finanziamenti pubblici 146
L’evoluzione della distribuzione del farmaco e dell'erogazione dei servizi in farmacia 146
Le start up 144
The nature, causes, and effects of skepticism on technology diffusion 143
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 143
Cost analysis of technological vs. conventional upper limb rehabilitation for patients with neurological disorders: an Italian real-world data case study 138
Strumenti per favorire gli investimenti e la competitività delle imprese 137
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients’ care pathway 135
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 133
Valutazione dei risultati di una gara 129
Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4) 125
EYE ON PACK. Visual search strategies in food choice 115
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 114
Analysis and Synthesis in Information Processing and Knowledge Creation 112
Propedeutica alle scienze Sperimentali. Introduzione al metodo scientifico e all'inferenza statistica. 112
The organizational dimension in rare and complex diseases care management: an application of RarERN Path© methodology in ataxias, dystonia and phenylketonuria 111
Valutazione dell’attività di malattia nei periodi di interruzione del trattamento con farmaci biologici modificanti la malattia reumatica in pazienti con artrite reumatoide 106
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 106
State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases 103
Industria 4.0 e Digitalizzazione 101
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study 81
null 63
Validazione degli algoritmi di selezione dei pazienti reumatologici nei database amministrativi toscani e traiettorie di aderenza ai farmaci biologici modificanti la malattia nell’artrite reumatoide 43
null 13
Totale 15.176
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021713 0 0 0 0 0 116 75 67 86 72 133 164
2021/2022745 23 141 29 50 9 15 96 159 56 70 31 66
2022/2023841 65 85 46 134 100 136 10 47 122 28 36 32
2023/2024465 43 18 61 22 18 62 51 38 7 26 29 90
2024/20253.729 66 86 245 184 272 264 565 871 307 171 467 231
2025/20265.667 504 1.192 1.623 1.203 1.001 144 0 0 0 0 0 0
Totale 15.176